Sperm Count Test Market Analysis

Sperm Count Test Market Analysis

The sperm count test market is segmented by technique into microscopy, chromatographic immunoassay & calorimetric reaction, smartphone-based, and others. The microscopy segment held the largest revenue size over USD 900 million in 2022 and is estimated to witness significant growth more than USD 1,530 million by 2032. Microscopy is an essential component of sperm count testing, as it allows for the visualization and analysis of sperm cells. Microscopy provides accurate and reliable results for sperm count testing, as it allows for the direct visualization and analysis of sperm cells. Additionally, microscopy can detect abnormalities in sperm cells, such as malformed or immotile sperm, which can provide valuable information for diagnosing male infertility.
 

Sperm count test market is bifurcated based on the age group including 34 years & below, 34 years, 35-40 years, 41 years & above. The 35-40 years segment is anticipated to witness highest CAGR at 5.7% during the forecast period owing to better accuracy. The 35-40 years age group is an important demographic for the market, as male fertility tends to decline with age, and this age range represents a critical window for couples trying to conceive. Furthermore, delayed childbearing, increased awareness of male infertility, lifestyle factors, medical conditions, and availability of testing are some of the key leading factors for the 35-40 years age group in the market.
 

The sperm count test market is segmented by end-use into fertility centres, hospital & clinics, and others. Fertility centres segment dominated the global market accounting for more than 42% revenue share in 2022 and is estimated to reach USD 1 billion by 2032. Sperm count tests are an essential part of male fertility testing and are routinely performed in fertility centers to diagnose male infertility and develop appropriate treatment plans. Additionally, the incidence of male infertility is on the rise, and this has increased the demand for sperm count testing in fertility centers. Therefore, increased availability of fertility treatments, and growing healthcare infrastructure are the key hammering factors for the use of sperm count tests in fertility centers.
 

U.S. sperm count test market accounted for more than USD 785 million in 2022 and is set to surpass USD 1.23 billion by 2032. Advancements in sperm count testing technology, favourable regulatory environment, and growing healthcare expenditure are the key driving factors for the U.S. market. Further, the rise in in-vitro fertilization services owing to increasing male infertility across the U.S. is anticipated to stimulate industry statistics. The U.S. has a favourable regulatory environment for medical devices and diagnostics, including sperm count tests. This has encouraged the development and commercialization of innovative sperm count testing technologies and has also increased the availability and accessibility of these tests.